Request Deal Involvement

Bain Capital Life Sciences and TCGX led a $200m Series C round in ADARx Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

ADARX PHARMACEUTICALS

target

ADARX PHARMACEUTICALS

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

TCGX

bidder

TCGX

BLACKROCK

bidder

BLACKROCK

COMMODORE CAPITAL

bidder

COMMODORE CAPITAL

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

HBM HEALTHCARE INVESTMENTS

bidder

HBM HEALTHCARE INVESTMENTS

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

MARSHALL WACE

bidder

MARSHALL WACE

REDMILE GROUP

bidder

REDMILE GROUP

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

VIVO CAPITAL LLC

bidder

VIVO CAPITAL LLC

ASCENTA CAPITAL

bidder

ASCENTA CAPITAL

LILLY ASIA VENTURES

bidder

LILLY ASIA VENTURES

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

SR ONE LTD

bidder

SR ONE LTD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite